These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1472145)

  • 1. Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimine.
    Freerksen E; Seydel JK
    Arzneimittelforschung; 1992 Oct; 42(10):1243-5. PubMed ID: 1472145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofazimine for leprosy and Mycobacterium avium complex infections.
    Med Lett Drugs Ther; 1987 Aug; 29(746):77-8. PubMed ID: 3614089
    [No Abstract]   [Full Text] [Related]  

  • 3. Clofazimine in the treatment of dapsone resistant leprosy.
    Taylor PM; Alexander R
    Lepr India; 1976 Oct; 48(4 Suppl):709-12. PubMed ID: 800234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM; Lamoureux LC; Gardner GD
    Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofazimine: new products. Major antileprous drug.
    Prescrire Int; 1999 Apr; 8(40):44-6. PubMed ID: 10848059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 8. Multi-drug therapy in bacilliferous leprosy--two years experience.
    Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
    Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology, metabolism, and chemistry of clofazimine.
    O'Connor R; O'Sullivan JF; O'Kennedy R
    Drug Metab Rev; 1995; 27(4):591-614. PubMed ID: 8925720
    [No Abstract]   [Full Text] [Related]  

  • 11. Field application of combined therapy for infectious leprosy cases. A feasibility study in Bombay.
    Ganapati R; Revankar CR; Naik SS
    Lepr India; 1983 Jul; 55(3):485-9. PubMed ID: 6656206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 14. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
    Mehta J; Gandhi IS; Sane SB; Wamburkar MN
    Indian J Lepr; 1985; 57(2):297-310. PubMed ID: 4078356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline reactions treated with clofazimine and corticosteroids.
    Thirugnanam T; Rajan MA
    Indian J Lepr; 1985; 57(1):164-71. PubMed ID: 3839816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug therapy in leprosy.
    Manglani PR; Arif MA
    J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of multidrug therapy on the treatment and control of leprosy.
    Gilbody JS
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):458-78. PubMed ID: 1890370
    [No Abstract]   [Full Text] [Related]  

  • 19. Clofazimine in lepra (ENL) reaction, one year clinical trial.
    Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
    Lepr India; 1983 Apr; 55(2):265-77. PubMed ID: 6355652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.